oMeds
All answers
Answer · hormone optimization

Which pathway addresses perimenopausal symptoms?

Short answer

Perimenopausal symptoms (cycle changes, sleep, mood, vasomotor, cognitive) are routed to BHRT after the standardized biomarker panel and synchronous provider review confirm candidacy.

Reviewed by Dr. Laura PurdyMay 29, 2026

Full answer

Perimenopause is the multi-year transition into menopause and is characterized by fluctuating, not strictly low, estradiol and progesterone. BHRT is the primary oMeds pathway, calibrated to cycle phase and biomarker context. Progesterone is often relevant for sleep, mood, and cycle stabilization; estradiol is calibrated to vasomotor and genitourinary symptoms; low-dose testosterone is considered for desire and energy when biomarkers match. Cardiovascular, thrombotic, and breast history are reviewed before initiation. Every plan is synchronous-video reviewed and recalibrated.

Educational. Not a substitute for individualized provider review.

References & sources
  • Bhrt Optimization pathway — Primary source · oMeds
  • Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29

Related pathways

All pathways →
Pathway
BHRT
A bioidentical, provider-reviewed pathway designed to support hormonal balance, recovery, sleep, and longitudinal wellbeing — informed by biomarkers, not guesswork.
Explore

Related answers

What is perimenopause?
Perimenopause is the 2-10 year transition before menopause marked by cycle irregularity and rising FSH. Estradiol fluctuates wildly; progesterone declines steadily.
Perimenopause vs menopause?
Perimenopause is the transition window — often 4–10 years long — during which estrogen and progesterone fluctuate dramatically while cycles remain present. Menopause is the clinical designation of 12 consecutive months without menses. Symptoms of perimenopause are frequently more volatile than menopause itself.
What causes perimenopause?
Perimenopause symptoms are driven by the increasingly erratic decline of ovarian estradiol and progesterone in the years before menopause. The variability — not just the absolute level — produces hot flashes, sleep disruption, mood shifts, irregular cycles, and cognitive changes.
Primary source
Bhrt Optimization pathway